tradingkey.logo


Concentra Group Holdings Parent Inc

CON

23.080USD

-0.460-1.95%
āđ€āļ§āļĨāļēāļ—āļģāļāļēāļĢāļ•āļĨāļēāļ” ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
2.96BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
19.87P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Concentra Group Holdings Parent Inc āļšāļĢāļīāļĐāļąāļ—
Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. The Company operates about 549 stand-alone occupational health centers in 41 states and 155 onsite health clinics at employer worksites in 37 states. It offers a comprehensive array of occupational health services, including workers’ compensation, employer and consumer health services. Its Occupational Health Centers segment encompasses the occupational health services it delivers at its 549 health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment consists of several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™CON
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Concentra Group Holdings Parent Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļJul 25, 2024
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. William Keith Newton
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™8758
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Jul 25
āļ—āļĩāđˆāļ­āļĒāļđāđˆC/O Select Medical Corporation
āđ€āļĄāļ·āļ­āļ‡ADDISON
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNYSE Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ75001
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ19723648000
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™CON
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļJul 25, 2024
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. William Keith Newton
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.25M
+13.96%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
257.83K
--
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
60.00K
--
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
60.00K
--
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
40.00K
--
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
Dr. Marc R. Watkins, M.D.
Dr. Marc R. Watkins, M.D.
Independent Director
Independent Director
--
--
Ms. Su Zan Nelson, CPA
Ms. Su Zan Nelson, CPA
Executive Vice President, Chief Accounting Officer
Executive Vice President, Chief Accounting Officer
--
--
Mr. Douglas R. Mcandrew
Mr. Douglas R. Mcandrew
Executive Vice President, Chief Operating Officer - West
Executive Vice President, Chief Operating Officer - West
--
--
Mr. Michael A. Kosuth
Mr. Michael A. Kosuth
Executive Vice President, Chief Operating Officer - East
Executive Vice President, Chief Operating Officer - East
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Robert A. Ortenzio
Mr. Robert A. Ortenzio
Chairman of the Board
Chairman of the Board
8.25M
+13.96%
Mr. William Keith Newton
Mr. William Keith Newton
Chief Executive Officer, Director
Chief Executive Officer, Director
257.83K
--
Mr. Thomas Devasia
Mr. Thomas Devasia
Executive Vice President, Chief Marketing and Innovation Officer
Executive Vice President, Chief Marketing and Innovation Officer
60.00K
--
Mr. Giovanni Gallara
Mr. Giovanni Gallara
Executive Vice President, Chief Clinical Services Officer
Executive Vice President, Chief Clinical Services Officer
60.00K
--
Ms. Danielle Kendall
Ms. Danielle Kendall
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
40.00K
--
Dr. John R. Anderson
Dr. John R. Anderson
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
--
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Occupational health centers - Workers compensation
302.11M
60.33%
Occupational health centers - Employer services
160.14M
31.98%
Onsite clinics
16.55M
3.31%
Other
11.28M
2.25%
Occupational health centers - Consumer health
8.61M
1.72%
Other occupational health center revenue
2.06M
0.41%
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Occupational health centers - Workers compensation
302.11M
60.33%
Occupational health centers - Employer services
160.14M
31.98%
Onsite clinics
16.55M
3.31%
Other
11.28M
2.25%
Occupational health centers - Consumer health
8.61M
1.72%
Other occupational health center revenue
2.06M
0.41%
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 27 āļŠ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 27 āļŠ.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
11.92%
T. Rowe Price Associates, Inc.
10.74%
The Vanguard Group, Inc.
10.26%
Ortenzio (Robert A)
6.43%
T. Rowe Price Investment Management, Inc.
5.98%
āļ­āļ·āđˆāļ™ āđ†
54.68%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
11.92%
T. Rowe Price Associates, Inc.
10.74%
The Vanguard Group, Inc.
10.26%
Ortenzio (Robert A)
6.43%
T. Rowe Price Investment Management, Inc.
5.98%
āļ­āļ·āđˆāļ™ āđ†
54.68%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
54.67%
Investment Advisor/Hedge Fund
18.61%
Individual Investor
9.95%
Hedge Fund
6.18%
Research Firm
2.47%
Pension Fund
1.28%
Sovereign Wealth Fund
1.21%
Bank and Trust
0.67%
Insurance Company
0.03%
āļ­āļ·āđˆāļ™ āđ†
4.92%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
431
121.77M
95.01%
-105.16M
2025Q1
426
119.93M
93.57%
-107.11M
2024Q4
358
124.20M
97.00%
-25.50M
2024Q3
110
131.78M
103.97%
+125.82M
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
15.28M
11.92%
-534.14K
-3.38%
Mar 31, 2025
T. Rowe Price Associates, Inc.
14.59M
11.38%
-2.61M
-15.20%
Mar 31, 2025
The Vanguard Group, Inc.
13.18M
10.28%
+1.07M
+8.86%
Jun 30, 2025
Ortenzio (Robert A)
8.25M
6.43%
+1.01M
+13.96%
Mar 03, 2025
T. Rowe Price Investment Management, Inc.
7.55M
5.89%
-1.06M
-12.30%
Mar 31, 2025
State Street Global Advisors (US)
4.22M
3.29%
-165.27K
-3.77%
Mar 31, 2025
Rocco A. Ortenzio UEO
3.30M
2.57%
-3.07M
-48.22%
Mar 03, 2025
Dimensional Fund Advisors, L.P.
3.26M
2.54%
-66.62K
-2.00%
Mar 31, 2025
Principal Global Investors (Equity)
2.44M
1.9%
+196.97K
+8.78%
Mar 31, 2025
JP Morgan Asset Management
2.54M
1.98%
+109.03K
+4.49%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 6 āļŠ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļļāļ˜āļ—āļĩāđˆ 6 āļŠ.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
SPDR S&P Health Care Services ETF
1.66%
Invesco S&P SmallCap Health Care ETF
1.47%
Janus Henderson Small Cap Growth Alpha ETF
1.16%
Harbor Human Capital Factor US Small Cap ETF
1.14%
Janus Henderson Small/Mid Cap Growth Alpha ETF
1.08%
JPMorgan Active Small Cap Value ETF
0.84%
T Rowe Price Small-Mid Cap ETF
0.61%
Invesco S&P SmallCap Quality ETF
0.61%
JPMorgan Fundamental Data Science Small Core ETF
0.59%
iShares U.S. Healthcare Providers ETF
0.36%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.66%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.47%
Janus Henderson Small Cap Growth Alpha ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.16%
Harbor Human Capital Factor US Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.14%
Janus Henderson Small/Mid Cap Growth Alpha ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™1.08%
JPMorgan Active Small Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.84%
T Rowe Price Small-Mid Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.61%
Invesco S&P SmallCap Quality ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.61%
JPMorgan Fundamental Data Science Small Core ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.59%
iShares U.S. Healthcare Providers ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.36%
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 7.96M USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Feb 28, 2025
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Apr 01, 2025 going ex on Mar 18, 2025
Mar 18, 2025
Apr 01, 2025
Mar 18, 2025
Oct 31, 2024
CON.NB Interim Cash Dividend of gross USD 0.0625 paid on Nov 22, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 22, 2024
Nov 13, 2024
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™